Iole Macchia

7PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Integrative Multidimensional Profiling of Individuals Recovered from Mild COVID-19 Reveals Immune-Metabolic-Oxidative Network Interactions.

|Oct 26, 2024
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.

Iole Macchia, Valentina La Sorsa, Alessandra Ciervo

|Sep 28, 2024
Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC).

Caterina Lapenta, Stefano Maria Santini, Celeste Antonacci

|Aug 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring".

Iole Macchia, Valentina La Sorsa, Irene Ruspantini

|Apr 24, 2020
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring.

Iole Macchia, Valentina La Sorsa, Irene Ruspantini

|Apr 16, 2020
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.

Alessandra Rossi, Valeria Lucarini, Iole Macchia

Pageof 2

Frequent Collaborators

6 joint publications

Francesca Urbani

3 joint publications

Giovanna Schiavoni

2 joint publications

Caterina Lapenta

2 joint publications

Simona Donati